Prolyl-Tyrosine Description
Prolyl-Tyrosine is a dipeptide composed of proline and tyrosine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite. Structure
Structure for HMDB29029 (Prolyl-Tyrosine)
Synonyms
Value Source L-Prolyl-L-tyrosineHMDB P-Y dipeptideHMDB pro-TyrHMDB Proline tyrosine dipeptideHMDB Proline-tyrosine dipeptideHMDB ProlyltyrosineHMDB PY dipeptideHMDB L-Prolyl-L-tyrosine monohydrateMeSH
Chemical Formlia
C14H18N2O4 Average Molecliar Weight
278.3037 Monoisotopic Molecliar Weight
278.126657074 IUPAC Name
3-(4-hydroxyphenyl)-2-(pyrrolidin-2-ylformamido)propanoic acid Traditional Name
3-(4-hydroxyphenyl)-2-(pyrrolidin-2-ylformamido)propanoic acid CAS Registry Number
Not Available SMILES
InChI Identifier
InChI Key
OIDKVWTWGDWMHY-UHFFFAOYSA-N Chemical Taxonomy Description
This compound belongs to the class of chemical entities known as dipeptides. These are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. Kingdom
Chemical entities Super Class
Organic compounds Class
Organic acids and derivatives Sub Class
Carboxylic acids and derivatives Direct Parent
Dipeptides Alternative Parents
Substituents
Molecliar Framework
Aromatic heteromonocyclic compounds External Descriptors
Not Available Ontology Status
Expected but not Quantified Origin
Biofunction
Not Available Application
Not Available Cellliar locations
Not Available Physical Properties State
Solid Experimental Properties
Property Value Reference Melting PointNot AvailableNot Available Boiling PointNot AvailableNot Available Water SolubilityNot AvailableNot Available LogP-1.75Extrapolated
Predicted Properties
Property Value Source Water Solubility1.18 mg/mLALOGPS logP-1.3ALOGPS logP-1.8ChemAxon logS-2.4ALOGPS pKa (Strongest Acidic)3.49ChemAxon pKa (Strongest Basic)9.98ChemAxon Physiological Charge0ChemAxon Hydrogen Acceptor Count5ChemAxon Hydrogen Donor Count4ChemAxon Polar Surface Area98.66 Å2ChemAxon Rotatable Bond Count5ChemAxon Refractivity71.96 m3·mol-1ChemAxon Polarizability28.62 Å3ChemAxon Number of Rings2ChemAxon Bioavailability1ChemAxon Rlie of FiveYesChemAxon Ghose FilterYesChemAxon Vebers RlieYesChemAxon MDDR-like RlieYesChemAxon
Spectra Spectra
Not Available Biological Properties Cellliar Locations
Not Available Biofluid Locations
Not Available Tissue Location
Not Available Pathways
Not Available Normal Concentrations Not Available Abnormal Concentrations
Not Available Associated Disorders and Diseases Disease References
None Associated OMIM IDs
None External Links DrugBank ID
Not Available DrugBank Metabolite ID
Not Available Phenol Explorer Compound ID
Not Available Phenol Explorer Metabolite ID
Not Available FoodDB ID
Not Available KNApSAcK ID
Not Available Chemspider ID
Not Available KEGG Compound ID
Not Available BioCyc ID
Not Available BiGG ID
Not Available Wikipedia Link
Not Available NuGOwiki Link
HMDB29029 Metagene Link
HMDB29029 METLIN ID
Not Available PubChem Compound
Not Available PDB ID
Not Available ChEBI ID
Not Available
Product: APS-2-79 (hydrochloride)
References Synthesis Reference Not Available Material Safety Data Sheet (MSDS) Not Available General References- Zherdev VP, Boiko SS, Mesonzhnik NV, Appolonova SA, Rodchenkov GN, Ostrovskaia RU, Gudasheva TA, Seredenin SB: [Experimental pharmacokinetics of the new neurotensine-derived antipsychotic drug dilept]. Eksp Klin Farmakol. 2009 May-Jun;72(3):16-21. [PubMed:19642587 ]
- Asmakova LS, Kalinina TS, Ostrovskaya RU, Gudasheva TA, Zaitseva NI, Bondarenko NA, Voronina TA, Seredenin SB: Comparison of antipsychotic activity and discriminative stimulus effects of the novel acylprolyltyrosine containing compound, GZR-123, and sulpiride. Pharmacol Biochem Behav. 1999 Oct;64(2):359-62. [PubMed:10515313 ]
- Shubenina EB, Kudrin VS, Klodt PM, Pokrovskii AA, Gudasheva TA, Voronina TA, Ostrovskaia RU: [Interstrain differences in the content of excitatory and inhibitory amino acids in the brain of DBA/2J, Balb/c and C57BL/6 mice: characteristics of the effect of a dipeptide antipsychotic drug dilept]. Eksp Klin Farmakol. 2008 Jul-Aug;71(4):7-10. [PubMed:18819433 ]
- Gu Y, Zhang J, Wang YB, Li SW, Yang HJ, Luo WX, Xia NS: [Selection of a peptide mimic the neutralization epitope of hepatitis E virus with phage peptide display technology]. Sheng Wu Gong Cheng Xue Bao. 2003 Nov;19(6):680-5. [PubMed:15971579 ]
- Gao S, Alarcon C, Sapkota G, Rahman S, Chen PY, Goerner N, Macias MJ, Erdjument-Bromage H, Tempst P, Massague J: Ubiquitin ligase Nedd4L targets activated Smad2/3 to limit TGF-beta signaling. Mol Cell. 2009 Nov 13;36(3):457-68. doi: 10.1016/j.molcel.2009.09.043. [PubMed:19917253 ]